Drug Safety, Parts 1-2U.S. Government Printing Office, 1964 |
From inside the book
Results 1-5 of 100
Page 27
... compounds through their infrared spectra . Reorganization of 1963 By far and away , however , the most important recent step taken to prepare FDA to meet more adequately its responsibilities in all areas , including drugs , was the ...
... compounds through their infrared spectra . Reorganization of 1963 By far and away , however , the most important recent step taken to prepare FDA to meet more adequately its responsibilities in all areas , including drugs , was the ...
Page 88
... compound , or process drugs solely for use in the course of their professional practice . ( c ) Persons in any State who manufacture , propagate , compound , or process drugs solely for use in research , teaching , or chemical analysis ...
... compound , or process drugs solely for use in the course of their professional practice . ( c ) Persons in any State who manufacture , propagate , compound , or process drugs solely for use in research , teaching , or chemical analysis ...
Page 97
... compound , or process drugs solely for use in the course of their professional practice . ( c ) Persons in any State who manufacture , prepare , propagate , compound , or process drugs solely for use in research , teaching , or chemical ...
... compound , or process drugs solely for use in the course of their professional practice . ( c ) Persons in any State who manufacture , prepare , propagate , compound , or process drugs solely for use in research , teaching , or chemical ...
Page 151
... compounds arise from the metabolism of the drug by the body . 4. The influence of other chemicals , such as other drugs or even articles of food or drink upon the activity of the drug in question . 5. How the activity of the drug in ...
... compounds arise from the metabolism of the drug by the body . 4. The influence of other chemicals , such as other drugs or even articles of food or drink upon the activity of the drug in question . 5. How the activity of the drug in ...
Page 164
... compounds , including information developed from statutory requirements . ( 2 ) Clarification of concepts and terms relating to new terminology . The Food and Drug Administration designates the Director of the Bureau of Medicine as the ...
... compounds , including information developed from statutory requirements . ( 2 ) Clarification of concepts and terms relating to new terminology . The Food and Drug Administration designates the Director of the Bureau of Medicine as the ...
Other editions - View all
Common terms and phrases
activities additional adequate adverse drug reactions adverse reactions advertisement agency American Medical Association animal tests animals antibiotic approved batch Chairman chemical chloramphenicol clinical investigations Commissioner of Food committee compounds concerning contraindications Cosmetic Act Department of Health disease dosage form Drug Administration Drug Amendments drug application Education established name evaluation exemption experience facilities FDA's Federal Food Federal Register Food and Drug FOUNTAIN GOLDBERG Government GRAY hearing examiner hospitals HUSSEY industry ingredient inspection Institutes investigational drugs labeling laboratory LARRICK manufacturer manufacturing practice ment metabolism MIDER National new-drug application operations package Packaging and labeling patients pharmaceutical pharmacology physicians prescription drug problems procedures processing proprietary name Public Health records reports responsible safe samples scientific scientists side effects specific sponsor staff Stat statement studies subcommittee submitted substance supplemental application tests therapeutic tion toxicity Welfare